Many people throughout the world do not have access to good health because they can’t afford expensive medicines.
We are committed to providing access to affordable and innovative medicines, driven by our purpose of ‘Good Health Can’t Wait’.
Our products and services are spread across our core businesses of Active Pharmaceutical Ingredients (API), generics, branded generics, biosimilars and over-the-counter pharmaceutical products around the world. We work towards meeting unmet patients needs in the areas of cardiovascular, diabetology, nephrology .
Elxavier was established with a vision to make medicines accessible to everyone. Beginning with the launch of GLYRIZ (Dapagliflozin) and GLYRIZ M ( Dapagliflozin and Metformin ) for T2DM, Heart failure and CKD patients with most affordable price.
We accelerate access to affordable and innovative medicines to help patients lead a healthier life.